Bengt Winblad has been Professor of Geriatric Medicine at the Karolinska Institute and Chief `Physician at the Karolinska University Hospital, Huddinge, Sweden since 1987. Professor Winblad is involved in an array of research activities. He is the Director of the Karolinska Institute's Alzheimer's Disease Research Center (KI-ADRC) including KASPAC (KI Dainippon Sumitomo Alzheimer Center) and the programme Swedish Brain Power. He serves as a reviewer of research centres in Europe and the United States. His research interests include the epidemiology, molecular genetics, pathology, biochemistry, clinical evaluation and treatment of dementia. Professor Winblad has authored more than 800 original publications in gerontology, geriatrics, and dementia research, and is a member of the editorial boards of 10 international scientific journals. He is a member of the Nobel Assembly for the Prize of Medicine and Physiology at the Karolinska Institute since 1988 and was elected Chairman of the Medical Scientific Advisory Panel (MSAP) of the Alzheimer's Disease International (ADI) in 1995. He received the Swedish Society of Medicine Alzheimer Award in 1994; the Royal Swedish Academy of Medical Sciences Award in 1997; the Norage Kabi Pharmacia Awards; the Alois Alzheimer Award in 1997, the Nordic Prize in Gerontology in 2002 and the IPA Recognition Award for Service to the Field of Psychogeriatrics in 2005.

Khalid Iqbal is Professor and Chairman, Department of Neurochemistry, at the New York State Institute for Basic Research in Staten Island, New York and, along with Winblad, a founder of the biennial International Conferences on Alzheimer's Disease & Related Disorders, (ICAD). Dr. Iqbal has authored over 200 scientific papers in prestigious American and international scientific journals and edited eight books on research advances in Alzheimer's Disease. His major research interests are the neurobiology of Alzheimer disease and related neurodegenerative disorders, especially the molecular mechanisms of neurofibrillary degeneration, a specific type of nerve cell death which predominates Alzheimer disease and related disorders. His pioneering studies on neuronal protein pathology and discoveries of the involvement of the tau protein and its abnormal hyperphosphorylation in Alzheimer disease have won him several prestigious honours and awards, including the Potamkin Prize from the American Academy of Neurology and the Zenith Award from the Alzheimer's Association, U.S.A.

Dag Aarsland is Professor of Geriatric Psychiatry, University of Bergen, School of Medicine, Institute of Psychiatry and Head of the Centre for Neuropsychiatric Research, Stavanger. In 2001 Professor Aarsland received the Leon Jarner prize for his research on Alzheimer's disease. Professor Aarsland is also member of the editorial board of International Psychogeriatrics.

Samuel Gandy is Sinai Professor of Alzheimer's Disease Research, Professor of Neurology and Psychiatry, and Associate Director of the Mount Sinai Alzheimer's Disease Research Center, and Chair, National Medical and Scientific Advisory Council of the Alzheimer's Association. Dr. Gandy is an international expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. In 1989, Gandy and his team discovered the first drugs that could lower formation of amyloid. Dr. Gandy has written more than 150 original papers, chapters and reviews on this topic. Dr. Gandy received his M.D. and Ph.D. at the Medical University of South Carolina. He did his postgraduate work at the Columbia University College of Physicians & Surgeons and Cornell University Medical College. Dr. Gandy completed his post doctorate at The Rockefeller University, where he was appointed assistant professor in the laboratory of Paul Greengard, 2000 Laureate of the Nobel Prize in Physiology or Medicine. Gandy was appointed associate professor of neurology and neurosciences at Cornell University Medical College in 1992. In 1997, he moved to New York University where he served as professor of psychiatry and cell biology until his appointment as Paul C. Brucker, M.D., Professor of Neuroscience at Jefferson Medical College and Director of the Farber Institute for Neurosciences in 2001. In July, 2007, he assumed his current post as Sinai Professor of Alzheimer's Disease Research at the Mount Sinai School of Medicine, New York.